Ann: Immutep Corporate Presentation, page-10

Haha ..We will see! It’s fun to speculate and crystal ball gaze
Its not going to start until mid next year at the earliest, imo. Our funds will see us through next year easily including starting the phase3. At some point in 2023 we will need to raise again anyway. By then other developments and a running phase3 trial may have significantly increased the share price and a 100 mil raise may look like small beer. IMU has done it off the back of hype alone.
Of course this is all perfect world speculation. But if we have our phase3 trial running successfully around the same time our autoimmune program hits the clinic and blockbuster results from our fast tracked Tact-003 phase2b are rolling in ( not to mention everything else). Then Immutep looks a very different company.